SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart ...

The initiation of the Phase 3 clinical trial VERSATILE-003 marks a significant milestone for PDS Biotechnology, signaling progress in their lead program targeting advanced HPV16-positive head and ...

The Company will provide a clinical, regulatory, and development update, including further details on the Phase 3 trial. To register, click here. About LPCN 1154 ...

The STOP-HS clinical trial program includes two Phase 3 studies, STOP-HS1 (NCT05620823) and STOP-HS2 (NCT05620836), evaluating the efficacy and safety of povorcitinib (INCB54707) in adult patients ...

The phase 3, randomized, open-label, parallel-group clinical trial (Clinical Trial Registration Number: CTR20251345) of BAT8006 is designed to assess the efficacy of BAT8006 versus investigator's ...

Send comments and news tips to [email protected]. Cite this: Phase 3 Trial Supports Ixekizumab in Treatment of Juvenile PsA, Enthesitis-Related Arthritis - Medscape - June 20, 2024.

Neumora halts trial of depression drug, rethinks 2 others to apply lessons from phase 3 failure By James Waldron Mar 3, 2025 11:00am Neumora Therapeutics depression Chutes and Ladders clinical ...

After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its lead ulcerative colitis candidate.  | After a long, cash-strapped journey, ...